HIIT Versus IMT on Modulating Blood Rheology in CAD Risk Factors

NCT ID: NCT03506984

Last Updated: 2018-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-01

Study Completion Date

2018-05-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participants had randomly divided into two equal groups. Group (A) had received a program of high intensity interval training 30-40 minutes three times per week for one month. The participant will start cycling slowly for five minute without resistance at the beginning of the exercise as warming up, then the active phase will last 20-30 minutes, then decrease the speed with no resistance at the end of the exercise as cooling down. Group (B) will receive a program of inspiratory muscle training by using the threshold based inspiratory muscle trainer for 10-15 minute daily with frequency three times per week for four weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Training Procedure for group (A):

1. Each participant had signed a consent form after receiving a detailed explanation about the procedure.
2. BMI had been measured body weight(Kg) and height (m2)

a. BMI= body weight (Kg)/ height (m2).
3. Resting pulse rate had been measured to the participant three successive times then the mean had to be taken.
4. A blood sample had been taken by a nurse in a heparinized tube and delivered to lab within six hours.
5. The participant had been asked to walk as quickly as he could in a 30-meter pre-measured flat walking area with interval markings every three meters for six minutes. Cones or brightly colored tape to mark boundaries of the walkway with cones placed at the beginning and end of the 30-meter boundary to indicate turns. (Actual distance). (BALKE 1963)
6. Teaching the participant had been reached how to perform high interval training exercise.
7. The load had been determined according to maximum heart rate obtained from cardiopulmonary exercise testing performed by cardiologist.
8. high intensity (85% - 95% MHR) and the interval period (60% - 75% MHR) .(Gibala et al. 2006)
9. The participant's started by five minutes warming up on the bicycle ergometer with no resistance as shown in fig (8).
10. Then one minute of high intensity training followed by one and half minute of low intensity training for 20 to 30 minutes.
11. Finally, a five minutes of cooling down with no resistance had performed.
12. Post treatment evaluation had been done using step three, four and step five.

Training Procedure for group (B):

1. Each participant had signed a consent form after receiving a detailed explanation about the procedure.
2. BMI had been measured body weight(Kg) and height (m2)

a. BMI= body weight (Kg)/ height (m2).
3. Resting pulse rate had been measured to the participant three successive times then the mean had to be taken.
4. A blood sample had been taken by a nurse in a heparinized tube and delivered to lab within six hours.
5. The participant had been asked to walk as quickly as he could in a 30-meter pre-measured flat walking area with interval markings every three meters for six minutes. Cones or brightly colored tape to mark boundaries of the walkway with cones placed at the beginning and end of the 30-meter boundary to indicate turns. (Actual distance). (BALKE 1963)
6. Teaching the participant had been teached how to use the threshold based Inspiratory muscle trainer device.
7. The load had been determined according to 10 maximum repetitions (10RMax).
8. The intensity had been 60% to 80% of the participant's maximal effort.(Enright \& Unnithan 2011)
9. The Inspiratory Muscle Trainer had been applied for (10 to 15) minutes once daily with frequency three times per week for four weeks as shown in fig (9).
10. Post treatment evaluation had been done using step three, four and step five.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease, Early-Onset

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will randomely divided into two equal groups. Group (A) will receive a programe of high intensity interval training 30-40 minutes three times per week for one month.the participant will start cycling slowly for five minute without resistance at the beginning of the exercise as warming up, then the active phase will last 20-30 minutes, then decrease the speed with no resistance at the end of the exercise as cooling down. The participant will be closely monitored by the handheld telemetry. Group (B) will receive a program of inspiratory muscle training by using the threshold based inspiratory muscle trainer for 10-15 minutesonce daily with frequency three times per week for four weeks.
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
the participant

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

the participant will do a program of inspiratory muscle training for 10-15 minutes once daily using Threshold Inspiration Muscle Training Device

Group Type EXPERIMENTAL

Threshold Inspiration Muscle Training Device

Intervention Type DEVICE

Threshold based trainer is a small handled device.It includes a mouthpiece and a calibrated spring loaded valve. The valve control a constant inspiratory pressure training load and the patient must generate a suffient inspiratory pressure in order for the inspiratory valve to be opened and allow the air to be inhaled. The amount of resistance can be adjusted by varying the compression of the spring-loaded valve. Adjustment from 9cmH2o to 41cmH2o.

Group B

the participant will start cycling slowly for five minutes without resistance at the beginning of the exercise as warming up, then the active phase will last 20-30 minutes, then decrease the speed with no resistance at the end of the exercise as cooling down using Electronic Bicycle Ergometer

Group Type EXPERIMENTAL

Electronic Bicycle Ergometer

Intervention Type DEVICE

Electronic Bicycle equipped with electronic break, display screen, adjustable seat, handle bar and foot straps will be used in High interval intensity training.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Threshold Inspiration Muscle Training Device

Threshold based trainer is a small handled device.It includes a mouthpiece and a calibrated spring loaded valve. The valve control a constant inspiratory pressure training load and the patient must generate a suffient inspiratory pressure in order for the inspiratory valve to be opened and allow the air to be inhaled. The amount of resistance can be adjusted by varying the compression of the spring-loaded valve. Adjustment from 9cmH2o to 41cmH2o.

Intervention Type DEVICE

Electronic Bicycle Ergometer

Electronic Bicycle equipped with electronic break, display screen, adjustable seat, handle bar and foot straps will be used in High interval intensity training.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

respironics,cedarGrove,NJ 07009-1201 Made in U.S.A Biodex LBC, made in New York

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. They will be 45-55 years old participants of males.
2. All of them had body mass index more than 30 kg/m2.
3. All of them were diagnosed as diabetic persons for at least 5 years.
4. All of them were diagnosed as a mild to moderate hypertensive persons for at least 5 years.
5. All of them had a reduction in walking capacity in relation to their height, age and body mass index (BMI).

Exclusion Criteria

1. Unstable cardiac condition.
2. Patient who were on beta blocker.
3. Uncontrolled diabetes mellitus.
4. Mentally unstable person.
5. Patient with intermittent claudication.
Minimum Eligible Age

45 Years

Maximum Eligible Age

55 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rana Elbanna

lecturer assistance at faculty of physical therapy at Cairo University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rana H Elbanna, master

Role: PRINCIPAL_INVESTIGATOR

lecturer assistance at faculty of physical therapy at Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ibri hospital

Ibri, Al Dhahra, Oman

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Oman

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rana H Elbanna, master

Role: CONTACT

00201120636626

Sherif O Elabd, master

Role: CONTACT

0096891107871

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohamed M Habib, master

Role: primary

0096899575015

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Rana Elbanna

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.